With the FIFA World Cup just months away, bosses have already come under huge pressure to reduce the cost for fans, but a new tier of tickets is only worsening the situation Read more
Dailystar Co Uk - Dec 27
Forest Hills Executive Home 4 B 3 Ba 3157 SF Brick Double lot Horace Kinsey Colleton Realty $559,900, (843)908-0613 Read more
Postandcourier - Dec 26
The flagship airline of Australia since 1922, Qantas Airways is currently in the process of preparing to overtake Singapore Airlines as the carrier running the longest flight in the world: dubbed as Project Sunrise over the fact that passengers on these two flights will be able to see two sunrise... Read more
Thestreet - Dec 26
Mark Wiseman has held high-profile roles in law, business consulting and finance, and will lead Canada’s efforts to reboot diplomatic relation with Washington at a critical moment. Read more
The New York Times - Dec 22
Google executive urges responsible AI development, citing collaborations brought about by President Donald Trump's "Genesis Mission" for energy and cybersecurity innovation. Read more
Fox Business - Dec 21
Friday on “The Alex Marlow Show,” CMS Administrator Dr. Mehmet Oz talked about price negotiations. Oz stated, “The president, he’s a good businessman and a good negotiator, says, go look at these pharma executives in the face and challenge them on this belief that they can charge us three times m... Read more
Brietbart - Dec 20
Human resources leaders need to hold themselves to consistent high standards, and that’s why the kiss cam couple is no longer working for Astronomer. Read more
Inc - Dec 19
The move could fuel more research and provide tax breaks to cannabis companies. Read more
Politico - Dec 18
The move reclassifies marijuana as a less dangerous drug and open new avenues for medical research, a major shift in federal drug policy that inches closer to the moves by many states including New York to completely decriminalize weed. Read more
New York Daily News - Dec 18The executive order reclassifies marijuana as a Schedule III drug, easing the path for more research. Read more
Business Insider - Dec 18